AG
ALBO
Artal Group’s Albireo Pharma, Inc. Common Stock ALBO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-600,000
| Closed | -$14M | – | 154 |
|
|
2021
Q4 | $14M | Hold |
600,000
| – | – | 0.38% | 54 |
|
|
2021
Q3 | $18.7M | Hold |
600,000
| – | – | 0.42% | 52 |
|
|
2021
Q2 | $21.1M | Hold |
600,000
| – | – | 0.43% | 47 |
|
|
2021
Q1 | $21.2M | Sell |
600,000
-100,000
| -14% | -$3.53M | 0.37% | 50 |
|
|
2020
Q4 | $26.3M | Sell |
700,000
-151,405
| -18% | -$5.68M | 0.56% | 44 |
|
|
2020
Q3 | $28.4M | Buy |
851,405
+351,045
| +70% | +$11.7M | 0.69% | 27 |
|
|
2020
Q2 | $13.3M | Sell |
500,360
-87,765
| -15% | -$2.32M | 0.37% | 48 |
|
|
2020
Q1 | $9.63M | Buy |
588,125
+137,925
| +31% | +$2.26M | 0.41% | 42 |
|
|
2019
Q4 | $11.4M | Hold |
450,200
| – | – | 0.44% | 38 |
|
|
2019
Q3 | $9M | Buy |
450,200
+200
| +0% | +$4K | 0.36% | 44 |
|
|
2019
Q2 | $14.5M | Sell |
450,000
-50,000
| -10% | -$1.61M | 0.59% | 30 |
|
|
2019
Q1 | $16.1M | Hold |
500,000
| – | – | 0.66% | 26 |
|
|
2018
Q4 | $12.3M | Hold |
500,000
| – | – | 0.45% | 27 |
|
|
2018
Q3 | $16.5M | Hold |
500,000
| – | – | 0.43% | 22 |
|
|
2018
Q2 | $17.8M | Sell |
500,000
-47,841
| -9% | -$1.7M | 0.38% | 17 |
|
|
2018
Q1 | $17.8M | Buy |
547,841
+247,841
| +83% | +$8.07M | 0.22% | 18 |
|
|
2017
Q4 | $7.68M | Buy |
+300,000
| New | +$7.68M | 0.12% | 27 |
|
|
2013
Q4 | – | Sell |
-290,740
| Closed | -$916K | – | 79 |
|
|
2013
Q3 | $916K | Hold |
290,740
| – | – | 0.03% | 40 |
|
|
2013
Q2 | $1.22M | Buy |
+290,740
| New | +$1.22M | 0.04% | 42 |
|